SG Americas Securities’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Sell
24,541
-7,655
-24% -$487K ﹤0.01% 1496
2025
Q4
$2.05M Sell
32,196
-19,201
-37% -$1.19M ﹤0.01% 1513
2025
Q3
$2.83M Buy
51,397
+43,349
+539% +$1.79M 0.01% 774
2025
Q2
$266K Buy
8,048
+1,317
+20% +$45.8K ﹤0.01% 2092
2025
Q1
$271K Buy
+6,731
New +$309K ﹤0.01% 2294
2024
Q4
Sell
-22,203
Closed -$1.17M 3235
2024
Q3
$1.17M Sell
22,203
-115,939
-84% -$6.46M ﹤0.01% 963
2024
Q2
$7.49M Buy
138,142
+129,057
+1,421% +$7.79M 0.05% 403
2024
Q1
$637K Sell
9,085
-14,073
-61% -$1.09M ﹤0.01% 1316
2023
Q4
$1.93M Sell
23,158
-1,221
-5% -$44.2K 0.02% 696
2023
Q3
$718K Buy
+24,379
New +$812K 0.01% 1521
2023
Q2
Sell
-46,654
Closed -$1.64M 2470
2023
Q1
$1.64M Buy
46,654
+43,156
+1,234% +$1.76M 0.02% 794
2022
Q4
$160K Sell
3,498
-2,093
-37% -$90.1K ﹤0.01% 2373
2022
Q3
$271K Sell
5,591
-3,631
-39% -$175K ﹤0.01% 2078
2022
Q2
$362K Sell
9,222
-40,422
-81% -$1.63M ﹤0.01% 2235
2022
Q1
$1.83M Sell
49,644
-14,157
-22% -$503K 0.02% 987
2021
Q4
$2.91M Sell
63,801
-3,128
-5% -$121K 0.02% 806
2021
Q3
$2.39M Buy
66,929
+50,152
+299% +$1.48M 0.01% 1106
2021
Q2
$332K Sell
16,777
-3,574
-18% -$83.9K ﹤0.01% 2121
2021
Q1
$473K Sell
20,351
-10,706
-34% -$229K ﹤0.01% 2056
2020
Q4
$645K Sell
31,057
-2,059
-6% -$37.6K ﹤0.01% 1799
2020
Q3
$717K Buy
33,116
+16,989
+105% +$397K 0.01% 1402
2020
Q2
$380K Sell
16,127
-31,637
-66% -$593K ﹤0.01% 2337
2020
Q1
$563K Buy
+47,764
New +$609K 0.01% 1757
2019
Q4
Sell
-14,708
Closed -$167K 3309
2019
Q3
$167K Buy
+14,708
New +$185K ﹤0.01% 2441
2019
Q2
Sell
-18,642
Closed -$151K 3148
2019
Q1
$151K Buy
+18,642
New +$137K ﹤0.01% 2769
2017
Q4
Sell
-9,360
Closed -$136K 3267
2017
Q3
$136K Sell
9,360
-4,946
-35% -$67.6K ﹤0.01% 2940
2017
Q2
$173K Buy
14,306
+6,052
+73% +$84.1K ﹤0.01% 2540
2017
Q1
$106K Sell
8,254
-7,297
-47% -$85.3K ﹤0.01% 2954
2016
Q4
$189K Buy
+15,551
New +$165K ﹤0.01% 2398

Other funds holding CYTK